Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Mehta

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Cancer Treatment Reports|August 1, 1977
High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicityA Nirenberg, C Mosende, B M Mehta, et al.
Nuclear Medicine and Biology|March 30, 1999
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiographyR Fonti, A Levchenko, B M Mehta, et al.
Neurology|September 1, 1979
Enhancement of CNS penetration of methotrexate by hyperosmolar intracarotid mannitol or carcinomatous meningitisH Hasegawa, J C Allen, B M Mehta, et al.
National Cancer Institute Monograph|April 1, 1981
Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor)H Juergens, C Kosloff, A Nirenberg, et al.
Scientific Reports|August 13, 2024
Value addition to dietetic frozen yoghurt through use of fruit peel solidsShaikh Adil, A H Jana, B M Mehta, et al.
Cancer Investigation|January 1, 1987
Systemic absorption of a leucovorin mouth wash: a pharmacologic studyJ J Fiore, N E Kemeny, B M Mehta, et al.
Cancer Treatment Reports|March 1, 1978
Serum distribution of citrovorum factor and 5-methyltetrahydrofolate following oral and im administration of calcium leucovorin in normal adultsB M Mehta, A L Gisolfi, D J Hutchison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1992
In-vivo identification of tumor multidrug resistance with 3H-colchicine [corrected]B M Mehta, E Rosa, J D Fissekis, et al.
Basic Life Sciences|January 1, 1991
Tumor heterogeneity and intrinsically chemoresistant subpopulations in freshly resected human malignant gliomasJ R Shapiro, B M Mehta, S A Ebrahim, et al.
National Cancer Institute Monograph|April 1, 1981
Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7)G Rosen, A Nirenberg, B Caparros, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Cancer Treatment Reports|August 1, 1977
High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicityA Nirenberg, C Mosende, B M Mehta, et al.
Nuclear Medicine and Biology|March 30, 1999
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiographyR Fonti, A Levchenko, B M Mehta, et al.
Neurology|September 1, 1979
Enhancement of CNS penetration of methotrexate by hyperosmolar intracarotid mannitol or carcinomatous meningitisH Hasegawa, J C Allen, B M Mehta, et al.
National Cancer Institute Monograph|April 1, 1981
Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor)H Juergens, C Kosloff, A Nirenberg, et al.
Scientific Reports|August 13, 2024
Value addition to dietetic frozen yoghurt through use of fruit peel solidsShaikh Adil, A H Jana, B M Mehta, et al.
Cancer Investigation|January 1, 1987
Systemic absorption of a leucovorin mouth wash: a pharmacologic studyJ J Fiore, N E Kemeny, B M Mehta, et al.
Cancer Treatment Reports|March 1, 1978
Serum distribution of citrovorum factor and 5-methyltetrahydrofolate following oral and im administration of calcium leucovorin in normal adultsB M Mehta, A L Gisolfi, D J Hutchison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1992
In-vivo identification of tumor multidrug resistance with 3H-colchicine [corrected]B M Mehta, E Rosa, J D Fissekis, et al.
Basic Life Sciences|January 1, 1991
Tumor heterogeneity and intrinsically chemoresistant subpopulations in freshly resected human malignant gliomasJ R Shapiro, B M Mehta, S A Ebrahim, et al.
National Cancer Institute Monograph|April 1, 1981
Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7)G Rosen, A Nirenberg, B Caparros, et al.
Pageof 5